Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for prevention of post-embolization complications after partial splenic embolization
ChiCTR-TRC-08000062Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypersplenism comparing Control / placebo arm with Celecoxib arm (2 arms). Primary endpoints: Complications after partial splenic embolization and Infarcted region and spleen volume after PSE. Started Apr 2008; status: completed.
02
Drugs
celecoxib
03
Conditions
hypersplenism
Beyond the preview
Go deeper on ChiCTR-TRC-08000062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000062.